BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Narayanan V, Weekes CD. Molecular therapeutics in pancreas cancer. World J Gastrointest Oncol 2016; 8(4): 366-379 [PMID: 27096032 DOI: 10.4251/wjgo.v8.i4.366]
URL: https://www.wjgnet.com/1948-5204/full/v8/i4/366.htm
Number Citing Articles
1
Sha Jin, Wei-Chun Lee, Daniela Aust, Christian Pilarsky, Nils Cordes. β8 Integrin Mediates Pancreatic Cancer Cell RadiochemoresistanceMolecular Cancer Research 2019; 17(10): 2126 doi: 10.1158/1541-7786.MCR-18-1352
2
Christina Schug, Aayush Gupta, Sarah Urnauer, Katja Steiger, Phyllis Fung-Yi Cheung, Christian Neander, Konstantinos Savvatakis, Kathrin A. Schmohl, Marija Trajkovic-Arsic, Nathalie Schwenk, Markus Schwaiger, Peter J. Nelson, Jens T. Siveke, Christine Spitzweg. A Novel Approach for Image-Guided 131I Therapy of Pancreatic Ductal Adenocarcinoma Using Mesenchymal Stem Cell-Mediated NIS Gene DeliveryMolecular Cancer Research 2019; 17(1): 310 doi: 10.1158/1541-7786.MCR-18-0185
3
Wen-Yan Xu, Qiang-Sheng Hu, Yi Qin, Bo Zhang, Wen-Sheng Liu, Quan-Xing Ni, Jin Xu, Xian-Jun Yu. Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysis <i>via</i> suppression of sirtuin 3 in pancreatic cancerWorld Journal of Gastroenterology 2018; 24(43): 4893-4905 doi: 10.3748/wjg.v24.i43.4893
4
Mei-Juan Tu, Pui Yan Ho, Qian-Yu Zhang, Chao Jian, Jing-Xin Qiu, Edward J. Kim, Richard J. Bold, Frank J. Gonzalez, Huichang Bi, Ai-Ming Yu. Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse modelsCancer Letters 2019; 442: 82 doi: 10.1016/j.canlet.2018.10.038
5
Yoichi Takakusagi, Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Masahiro Yasunaga, Yasuhiro Matsumura, Fumio Sugawara, Kengo Sakaguchi, Tatsuya Higashi. The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3Translational Oncology 2022; 15(1): 101285 doi: 10.1016/j.tranon.2021.101285
6
Muhammad Sardar, Alejandro Recio-Boiles, Kabir Mody, Christian Karime, Sreenivasa R Chandana, Daruka Mahadevan, Jason Starr, Jeremy Jones, Mitesh Borad, Hani Babiker. Pharmacotherapeutic options for pancreatic ductal adenocarcinomaExpert Opinion on Pharmacotherapy 2022; 23(18): 2079 doi: 10.1080/14656566.2022.2149322
7
Chunwan Lu, Dafeng Yang, Maria E. Sabbatini, Aaron H. Colby, Mark W. Grinstaff, Nicholas H. Oberlies, Cedric Pearce, Kebin Liu. Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cellsBMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4061-y
8
Dipesh Kumar Yadav, Xueli Bai, Rajesh Kumar Yadav, Alina Singh, Guogang Li, Tao Ma, Wei Chen, Tingbo Liang. Liquid biopsy in pancreatic cancer: the beginning of a new eraOncotarget 2018; 9(42): 26900 doi: 10.18632/oncotarget.24809
9
Aya Sugyo, Atsushi B. Tsuji, Hitomi Sudo, Mitsuru Koizumi, Yoshinori Ukai, Gene Kurosawa, Yoshikazu Kurosawa, Tsuneo Saga, Tatsuya Higashi. Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CD147 Monoclonal Antibody 059-053 in a BxPC-3 Xenograft Mouse Model of Refractory Pancreatic CancerInternational Journal of Molecular Sciences 2018; 19(10): 2979 doi: 10.3390/ijms19102979
10
Giulia Biondani, Katrine Zeeberg, Maria Raffaella Greco, Stefania Cannone, Ilaria Dando, Elisa Dalla Pozza, Maria Mastrodonato, Stefania Forciniti, Valeria Casavola, Marta Palmieri, Stephan Joel Reshkin, Rosa Angela Cardone. Extracellular matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretomeThe FEBS Journal 2018; 285(11): 2104 doi: 10.1111/febs.14471
11
Prosenjit Paul, Arup Kumar Malakar, Supriyo Chakraborty. The significance of gene mutations across eight major cancer typesMutation Research/Reviews in Mutation Research 2019; 781: 88 doi: 10.1016/j.mrrev.2019.04.004
12
Doaa Tawfik, Angela Zaccagnino, Alexander Bernt, Monika Szczepanowski, Wolfram Klapper, Albrecht Schwab, Holger Kalthoff, Anna Trauzold. The A818–6 system as an in-vitro model for studying the role of the transportome in pancreatic cancerBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-06773-w
13
Parthasarathy Seshacharyulu, Sushanta Halder, Ramakrishna Nimmakayala, Satyanarayana Rachagani, Sanjib Chaudhary, Pranita Atri, Ramakanth Chirravuri-Venkata, Michel M. Ouellette, Joseph Carmicheal, Shailendra K. Gautam, Raghupathy Vengoji, Shuo Wang, Sicong Li, Lynette Smith, Geoffrey A. Talmon, Kelsey Klute, Quan Ly, Bradley N Reames, Jean L Grem, Lyudmyla Berim, James C Padussis, Sukhwinder Kaur, Sushil Kumar, Moorthy P. Ponnusamy, Maneesh Jain, Chi Lin, Surinder K Batra. Disruption of FDPS/Rac1 axis radiosensitizes pancreatic ductal adenocarcinoma by attenuating DNA damage response and immunosuppressive signallingeBioMedicine 2022; 75: 103772 doi: 10.1016/j.ebiom.2021.103772
14
Farid G Khalafalla, Mohammad W Khan. Inflammation and Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma: Fighting Against Multiple OpponentsCancer Growth and Metastasis 2017; 10: 117906441770928 doi: 10.1177/1179064417709287
15
Carlo Fabbri, Giulia Gibiino, Adele Fornelli, Vincenzo Cennamo, Daniela Grifoni, Michela Visani, Giorgia Acquaviva, Matteo Fassan, Sirio Fiorino, Silvia Giovanelli, Marco Bassi, Stefania Ghersi, Giovanni Tallini, Elio Jovine, Antonio Gasbarrini, Dario de Biase. Team work and cytopathology molecular diagnosis of solid pancreatic lesionsDigestive Endoscopy 2017; 29(6): 657 doi: 10.1111/den.12845
16
Max M. Träger, Sameer A. Dhayat. Epigenetics of epithelial‐to‐mesenchymal transition in pancreatic carcinomaInternational Journal of Cancer 2017; 141(1): 24 doi: 10.1002/ijc.30626
17
Min Jung Lee, Jin-Young Cho, Sumi Bae, Hye Soo Jung, Chang Moo Kang, Sung Hyun Kim, Hye Jin Choi, Choong-kun Lee, Hoguen Kim, Daewoong Jo, Young-Ki Paik. Inhibition of the Alternative Complement Pathway May Cause Secretion of Factor B, Enabling an Early Detection of Pancreatic CancerJournal of Proteome Research 2024; 23(3): 985 doi: 10.1021/acs.jproteome.3c00695
18
Kathrin A. Schmohl, Aayush Gupta, Geoffrey K. Grünwald, Marija Trajkovic-Arsic, Kathrin Klutz, Rickmer Braren, Markus Schwaiger, Peter J. Nelson, Manfred Ogris, Ernst Wagner, Jens T. Siveke, Christine Spitzweg. Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) geneOncotarget 2017; 8(20): 33393 doi: 10.18632/oncotarget.16499